Danish regional health authority contributing clinical validation sites, patient populations, and public health implementation expertise to European research projects.
Region Midtjylland is the regional public health authority for Central Denmark, responsible for hospitals, public health services, and healthcare delivery across one of Denmark's largest regions. In H2020, they contribute real-world clinical environments, patient populations, and health system expertise to European research projects — particularly in patient empowerment, chronic disease management, cancer screening, and urban health. Their value lies in being a large-scale public health provider that can pilot, validate, and implement research interventions in actual healthcare settings.
EMPATTICS focused on empowering patients with chronic diseases, vCare on virtual coaching for elderly rehabilitation, and CBIG-SCREEN on engaging vulnerable populations in screening.
CBIG-SCREEN addresses cervical cancer and HPV screening among vulnerable women, with focus on migration, socioeconomic inequalities, and proportional universalism.
HEART project investigates the health impact of blue-green urban regenerative technologies, including AI-based monitoring and behavioural change.
vCare developed virtual coaching for elderly rehabilitation; EMPATTICS improved patient communication systems — both using digital tools in clinical settings.
EMPATTICS used PCP funding to drive innovation procurement, and PROEIPAHA supported European Innovation Partnership on Active and Healthy Ageing.
In the early period (2015–2017), Region Midtjylland focused on chronic disease management, patient empowerment, and active healthy ageing — essentially digitizing and improving traditional healthcare delivery. From 2021 onward, their focus shifted decisively toward health equity, population-level screening for vulnerable groups (cervical cancer, HPV, migration health), and environmental determinants of health through urban blue-green interventions. The trajectory shows a move from individual patient-level digital health toward systemic, population-level public health challenges.
Moving toward implementation science for health equity — expect future projects addressing how to reach underserved populations with evidence-based interventions.
Region Midtjylland exclusively participates as a partner or third party — they have never coordinated an H2020 project. With 93 unique partners across 24 countries, they operate in large, diverse consortia and bring clinical infrastructure rather than project leadership. This makes them an ideal validation partner: they offer access to real patient populations and healthcare systems without competing for the coordination role.
Broad European network spanning 93 partners across 24 countries, indicating they are well-connected across the continent rather than clustered in a Nordic subgroup. Their diverse project topics attract different partner constellations each time rather than a fixed circle of collaborators.
As a regional health authority — not a university or research institute — Region Midtjylland offers something most consortium partners cannot: direct governance over hospitals, clinics, and public health programmes serving a real population of 1.3 million. This means they can pilot interventions at scale in an operational healthcare system, not just in a lab or a small trial. For any project needing a Nordic clinical validation site with strong public health infrastructure, they are a natural fit.
